Two recent studies from researchers at Washington University School of Medicine in St. Louis have identified a promising way ...

Two new studies have identified a possible way to block the progression of several forms of blood cancer using a drug already in clinical trials against breast cancer.

The investigational drug, called PMD-026, is currently in phase 2 clinical trials for the treatment of breast cancer.

Two new studies led by researchers at Washington University School of Medicine in St. Louis have identified a possible way to block the progression of several forms of blood cancer using a drug ...

Two new studies led by researchers at Washington University School of Medicine in St. Louis have identified a possible way to block the progression of ...

Two new studies led by researchers at Washington University School of Medicine in St. Louis have identified a possible way to block the progression of several forms of blood cancer using a drug ...